PATENT CLAIM ANALYSIS

Application Number: 16446098
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "262100"]

Abstract:
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Claim (Index 51):
The compound of  claim 44 , selected from:\n 4-\u250c1-(4-amino-3-methyl-1H-pyrazolo\u250c3,4-d\u2510pyrimidin-1-yl)ethyl\u2510-6-chloro-3-ethoxy-2-(2-oxo-1,3-oxazolidin-5-yl)benzonitrile; 5-{3-\u250c1-(4-Amino-3-methyl-1H-pyrazolo\u250c3,4-d\u2510pyrimidin-1-yl)ethyl\u2510-5-chloro-2-methoxy-6-methylphenyl}-1,3-oxazolidin-2-one; and 5-{3-[1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl}-1,3-oxazolidin-2-one, or a pharmaceutically acceptable salt thereof of any of the aforementioned.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 100.0
- Lexical Diversity: 1.41463
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14872881', '15673529', '16112160', '14872918', '13601349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8204701251944851
- 35 USC 102 Novelty (BERT): 0.6827812355797436
- Combined Prediction Score: 0.806701236233011
- Mean Citation Score: 622.894354
- Max Citation Score: 758.6226
- Similarity Product: 650.8260993843197

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test